Altered expression of endothelin receptors in failing human left ventricles

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 7, 2002, Pages 833-846

  Asano, Koji ^a   Bohlmeyer, Teresa J ^a   Westcott, Jay Y ^b   Zisman, Lawrence ^a   Kinugawa, Koichiro ^a   Good, Matthew ^a   Minobe, Wayne A ^a   Roden, Robert ^a   Wolfel, Eugene E ^a   Lindenfeld, Joann ^a   David Port, J ^a   Perryman, M Benjamin ^a   Clevel, Joseph ^a   Lowes, Brian D ^a   Bristow, Michael R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Endothelin; Endothelin receptor gene expression; Heart failure; In situ polymerase chain reaction

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GUANINE NUCLEOTIDE; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE EXPRESSION; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE FIBER MEMBRANE; HEART VENTRICLE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LEYDIG CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; TISSUE LEVEL;

EID: 18644368829     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2022     Document Type: Article

References (49)

1. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
2. B receptors in the hypertrophic effects of ET-1 in rabbit ventricular cardiomyocytes. J Cardiovasc Pharmacol 1997; 29: 350-359.
3. Love M, McMurray JJV. Endothelin in congestive heart failure. Basic Res Cardiol 1996; 91: 21-29.
4. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992; 85: 504-509.
5. Wei C-M, Lerman A, Rodeheffer RJ, McGregor CGA, Brabdt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC. Endothelin in human congestive heart failure. Circulation 1994; 89: 1580-1586.
6. Shimoyama H, Sabbah HN, Borzak S, Tanimura M, Shevlyyagin S, Scicli G, Goldstein S. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation 1996; 94: 779-784.
7. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996; 384: 353-355.
8. Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation 1997; 95: 1918-1929.
9. Ponicke K, Vogelsang M, Heinroth M, Becker K, Zolk O, Böhm M, Zerkowski H-R, Brodde O-E. Endothelin receptors in the failing and nonfailing human heart. Circulation 1998; 97: 744-751.
10. Pieske B, Beyermann B, Breu V, Löffler BM, Schlotthauer K, Maier LS, Schmidt-Scheda S, Just H, Hasenfuss G. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 1999; 99: 1802-1809.
11. Zolk O, Quattek J, Sitzler G, Schrader T, Nickenig G, Chnabel P, Shimada K, Takahashi M, Böhm M. Expression of endothelin-1. endothelin-converting enzyme. and endothelin receptors in chronic heart failure. Circulation 1999; 99: 2118-2123.
12. Serneri GG, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, Janming X, Bertolozzi I, Boddi M, Lisi GF, Sani G, Modesti PA. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ Res 2000; 86: 377-385.
13. Walker CA, Ergul A, Grubbs A, Zile MR, Zellner JL, Crumbley AJ, Spinale FG. β-adrenergic and endothelin receptor interaction in dilated cardiomyopathic myocardium. J Cardiac Failure 2001; 7: 129-137.
14. Bristow MR. Changes in myocardial and vascular receptors in heart failure. JACC 1993; 22: 61-71.
15. Rodbard D. Mathematics of hormone-receptor interaction I. Basic Principles. In: O'Malley BW and Means AR (eds). Receptors for Reproductive Hormones. NY, London: Plenum Press, 1973.
16. 1-receptor subtype in failing human ventricular myocardium. Circulation 1997; 95: 1193-1200.
17. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982; 307: 205-211.
18. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986; 74: 1290-1302.
19. A receptor. Life Sci 1992; 50: 247-255.
20. GraphPad InPlot Version 3.1. Scientific Graphics and Curve Fitting 1990. GraphPad Software, San Diego. CA, USA.
21. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977; 83: 346-356.
22. Miyamoto Y, Yoshimasa T, Arai H, Takaya K, Ogawa Y, Itoh H, Nakao K. Alternative splicing of the human endothelin-A receptor generates multiple transcripts. Biochem J 1996; 313: 795-801.
23. Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J, Feldman AM. Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991; 84: 1024-1039.
24. A receptor mRNA and increases responsiveness to endothelin-1 of rat aortic smooth muscle cells in primary culture. Biochem Biophys Res Commun 1992; 188: 719-726.
25. Eichhorn EJ, Bristow MR. Medical therapy improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 1996; 94: 2285-2296.
26. B receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules. Biochem Biophys Res Commun 1992; 186: 342-347.
27. B receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem Biophys Res Commun 1993; 194: 1282-1287.
28. B receptors. J Appl Physiol 1996; 81: 1510-1515.
29. B receptors in local clearance of endothelin-1 in rat heart: studies with the antagonists PD 155080 and BQ-788. FEBS Lett 1996; 396: 238-242.
30. B-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem Biophys Res Commun 1995; 209: 483-489.
31. Spatz M, Kawai N, Merkel N, Bembry J, McCarron RM. Functional properties of cultured endothelial cells derived from large microvessels of human brain. Am J Physiol 1997; 272 (Cell Physiol): C231-C239.
32. A receptor in endothelium of rabbit aortic valve. J Pharmacol Exp Ther 1994; 271: 1359-1364.
33. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 1993; 72: 526-538.
34. Hosoda K, Nakao K, Hiroshi-Arai, Suga S, Ogawa Y, Mukoyama M, Shirakami G, Saito Y, Nakanishi S, Imura H. Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett 1991; 287: 23-26.
35. Maguire JJ, Kuc RE, O'Reilly G, Davenport AP. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol 1994; 113: 49-54.
36. Rossi G, Albertin G, Belloni A, Zanin L, Biasolo MA, Prayer-Galetti T, Bader M, Nussdorfer GG, Palu G, Pessina AC. Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex. J Clin Invest 1994; 94: 1226-1234.
37. Davenport AP, Kuc RE, Hoskins SL, Karet FE, Fitzgerald F. [125I]-PD151242: a selective ligand for endothelin ETA receptors. Br J Pharmacol 1994; 113: 1303-1310.
38. Karet FE, Kuc RE, Davenport AP. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kideny. Kidney Int 1993; 44: 36-42.
39. Karam H, Valdenaire O, Belair MF, Prigent-Sassy C, Rakotosalama A, Clozel M, Itskovitz J, Bruneval P. The endothelin system in human and monkey ovaries: in situ gene expression of the different components. Cell Tissue Res 1999; 295: 101.
40. Louden CS, Nambi P, Pullen MA, Thomas RA, Tierney LA, Solleveld HA, Schwartz LW. Endothelin receptor subtype distribution predisposes coronary arteries to damage. Am J Pathol 2000; 157: 123-134.
41. Karet FE, Endothelin peptides and receptors in human kidney. Clin Sci (Lond) 1996; 9: 267-273.
42. Isaka M, Takaoka K, Yamada Y, Abe Y, Kitazawa T, Taneike T. Characterization of functional endothelin receptors in the porcine myometrium. Peptides 2000; 21: 543-551.
43. Russell FD, Skepper JN, Davenport AP. Detection of endothelin receptors in human coronary artery smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J Cardiovasc Pharmacol 1997; 29: 820-826.
44. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res. 1993; 27: 2130-2134.
45. Sakamoto A, Yanagisawa M, Sakurai T, Takuwa Y, Yanagisawa H, Masaki T. Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophys Res Commun 1991; 31: 178: 656-663.
46. Modesti PA, Vanni S, Paniccia R, Bandinelli B, Bertolozzi I, Polidori G, Sani G, Neri Serneri GG. Characterization of endothelin-1 receptor subtypes in isolated human cardiomyocytes. J Cardiovasc Pharmacol 1999; 34: 333-335.
47. Woolf PD, Hamell RW, Lee LA, Cox C, McDonald JV. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg 1987; 66: 872-882.
48. Lopau K, Mark J, Schramm L, Heidbreder E, Wanner C. Hormonal changes in brain death and immune activation in the donor. Transpl Int 2000; 13: S282-S285.
49. Mallat A, Fouassier L, Preaux AM, Mavier P, Lotersztajn S. Antiproliferative effects of ET-1 in human liver Ito cells: an ETB- and a cyclic AMP-mediated pathway. J Cardiovasc Pharmacol 1995; 26: S132-S134.